• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植术后肝细胞癌患者内脏肥胖与肿瘤复发的关系。

Association between visceral obesity and tumor recurrence in hepatocellular carcinoma recipients undergoing liver transplantation.

机构信息

Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Department of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Korea.

出版信息

Int J Obes (Lond). 2023 Dec;47(12):1214-1223. doi: 10.1038/s41366-023-01367-5. Epub 2023 Aug 28.

DOI:10.1038/s41366-023-01367-5
PMID:37640894
Abstract

BACKGROUND

Excessive visceral obesity in recipients of living donor liver transplantation (LDLT) is associated with mortality, and a recent study reported the correlation between visceral adiposity of male LDLT recipients and hepatocellular carcinoma (HCC) recurrence. However, there is no study on the relationship between the donor's visceral adiposity and surgical outcomes in LDLT recipients. We investigated the association of the visceral-to-subcutaneous fat area ratio (VSR) in donors and recipients with HCC recurrence and mortality in LDLT.

METHODS

We analyzed 1386 sets of donors and recipients who underwent LDLT between January 2008 and January 2018. The maximal chi-square method was used to determine the optimal cutoff values for VSR for predicting overall HCC recurrence and mortality. Cox regression analyses were performed to evaluate the association of donor VSR and recipient VSR with overall HCC recurrence and mortality in recipients.

RESULTS

The cutoff values of VSR was determined as 0.73 in males and 0.31 in females. High donor VSR was significantly associated with overall HCC recurrence (adjusted hazard ratio [HR]: 1.43, 95% confidence interval [CI]: 1.06-1.93, p = 0.019) and mortality (HR: 1.35, 95% CI: 1.03-1.76, p = 0.030). High recipient VSR was significantly associated with overall HCC recurrence (HR: 1.40, 95% CI: 1.04-1.88, p = 0.027) and mortality (HR: 1.50, 95% CI: 1.14-1.96, p = 0.003).

CONCLUSIONS

Both recipient VSR and donor VSR were significant risk factors for HCC recurrence and mortality in LDLT recipients. Preoperative donor VSR and recipient VSR may be strong predictors of the surgical outcomes of LDLT recipients with HCC.

摘要

背景

接受活体供肝肝移植(LDLT)的患者内脏肥胖过多与死亡率相关,最近的一项研究报告了男性 LDLT 受者内脏脂肪与肝细胞癌(HCC)复发之间的相关性。然而,目前尚无关于供者内脏脂肪与 LDLT 受者手术结果之间关系的研究。我们调查了供者和受者内脏与皮下脂肪面积比(VSR)与 LDLT 中 HCC 复发和死亡率的关系。

方法

我们分析了 2008 年 1 月至 2018 年 1 月期间接受 LDLT 的 1386 对供者和受者。最大卡方法用于确定 VSR 预测总体 HCC 复发和死亡率的最佳截断值。Cox 回归分析用于评估供者 VSR 和受者 VSR 与受者总体 HCC 复发和死亡率的关系。

结果

VSR 的截断值在男性中为 0.73,在女性中为 0.31。高供者 VSR 与总体 HCC 复发显著相关(调整后的危险比[HR]:1.43,95%置信区间[CI]:1.06-1.93,p=0.019)和死亡率(HR:1.35,95% CI:1.03-1.76,p=0.030)。高受者 VSR 与总体 HCC 复发显著相关(HR:1.40,95% CI:1.04-1.88,p=0.027)和死亡率(HR:1.50,95% CI:1.14-1.96,p=0.003)。

结论

受者 VSR 和供者 VSR 均是 LDLT 受者 HCC 复发和死亡的重要危险因素。术前供者 VSR 和受者 VSR 可能是 LDLT 合并 HCC 受者手术结果的有力预测指标。

相似文献

1
Association between visceral obesity and tumor recurrence in hepatocellular carcinoma recipients undergoing liver transplantation.肝移植术后肝细胞癌患者内脏肥胖与肿瘤复发的关系。
Int J Obes (Lond). 2023 Dec;47(12):1214-1223. doi: 10.1038/s41366-023-01367-5. Epub 2023 Aug 28.
2
Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.活体供肝移植与死亡供肝移植相比,肝癌复发率更高。
Transplantation. 2014 Jan 15;97(1):71-7. doi: 10.1097/TP.0b013e3182a68953.
3
Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.与尸体供肝移植相比,活体供肝移植不会增加肝细胞癌的肿瘤复发率。
World J Gastroenterol. 2014 Aug 21;20(31):10953-9. doi: 10.3748/wjg.v20.i31.10953.
4
Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.小体积供肝移植增加了米兰标准以外肝癌肝移植的复发率。
Liver Transpl. 2018 Jan;24(1):35-43. doi: 10.1002/lt.24868.
5
Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.肝移植受者肝癌患者的生存结局:A2ALL 队列研究结果。
Am J Transplant. 2012 Nov;12(11):2997-3007. doi: 10.1111/j.1600-6143.2012.04272.x. Epub 2012 Sep 20.
6
Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation.在活体肝移植中,血小板计数较高的受者发生移植后肝细胞癌复发的风险更高。
Liver Transpl. 2018 Jan;24(1):44-55. doi: 10.1002/lt.24961. Epub 2017 Dec 8.
7
Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.ABO 不相容成人活体肝移植治疗肝细胞癌患者的结局。
J Hepatol. 2018 Jun;68(6):1153-1162. doi: 10.1016/j.jhep.2018.02.002. Epub 2018 Feb 13.
8
Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.供体肝移植后肝细胞肝癌患者的临床结局。
World J Gastroenterol. 2013 Aug 7;19(29):4737-44. doi: 10.3748/wjg.v19.i29.4737.
9
Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.活体供肝移植与死体供肝移植治疗肝细胞癌的比较:一项荟萃分析。
Liver Transpl. 2012 Oct;18(10):1226-36. doi: 10.1002/lt.23490.
10
Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.影响活体肝移植后肝细胞癌复发患者生存的预后因素:特别关注中性粒细胞/淋巴细胞比值。
Transplantation. 2013 Dec 15;96(11):1008-12. doi: 10.1097/TP.0b013e3182a53f2b.

引用本文的文献

1
Influence of body fat tissue on outcomes in patients undergoing hepatectomy or liver transplantation: a systematic review and meta-analysis.体脂组织对肝切除或肝移植患者预后的影响:一项系统评价和荟萃分析。
Int J Surg. 2025 Jan 1;111(1):1167-1181. doi: 10.1097/JS9.0000000000001864.

本文引用的文献

1
The effect of donor body mass index on graft function in liver transplantation: A systematic review.供体体重指数对肝移植中移植物功能的影响:系统评价。
Transplant Rev (Orlando). 2020 Oct;34(4):100571. doi: 10.1016/j.trre.2020.100571. Epub 2020 Sep 17.
2
Development and Validation of a Deep Learning System for Segmentation of Abdominal Muscle and Fat on Computed Tomography.基于深度学习的 CT 图像腹部肌肉和脂肪分割系统的建立与验证
Korean J Radiol. 2020 Jan;21(1):88-100. doi: 10.3348/kjr.2019.0470.
3
Predicting peripartum blood transfusion: focusing on pre-pregnancy characteristics.
预测围产期输血:关注孕前特征。
BMC Pregnancy Childbirth. 2019 Dec 5;19(1):477. doi: 10.1186/s12884-019-2646-3.
4
Reliable and robust method for abdominal muscle mass quantification using CT/MRI: An explorative study in healthy subjects.使用 CT/MRI 进行腹部肌肉质量定量的可靠且稳健的方法:健康受试者的探索性研究。
PLoS One. 2019 Sep 19;14(9):e0222042. doi: 10.1371/journal.pone.0222042. eCollection 2019.
5
Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.术前内脏脂肪过多和肌肉量少预示着肝细胞癌肝切除术后预后不良。
Liver Cancer. 2019 Mar;8(2):92-109. doi: 10.1159/000488779. Epub 2018 Jun 5.
6
Adipokine dysregulation and adipose tissue inflammation in human obesity.人肥胖症中的脂联素失调和脂肪组织炎症。
Eur J Clin Invest. 2018 Sep;48(9):e12997. doi: 10.1111/eci.12997. Epub 2018 Aug 3.
7
Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.内脏肥胖增加了肝硬化和肝移植后复发的男性患者发生肝细胞癌的风险。
Hepatology. 2018 Mar;67(3):914-923. doi: 10.1002/hep.29578. Epub 2018 Jan 26.
8
Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.肌肉减少症可预测新诊断的肝细胞癌患者的预后,与肿瘤分期和肝功能无关。
Cancer Res Treat. 2018 Jul;50(3):843-851. doi: 10.4143/crt.2017.232. Epub 2017 Sep 4.
9
Impact of Donor Age on Recipient Survival in Adult-to-Adult Living-donor Liver Transplantation.供体年龄对成人活体肝移植受者生存的影响。
Ann Surg. 2018 Jun;267(6):1126-1133. doi: 10.1097/SLA.0000000000002194.
10
Adult-to-adult living donor liver transplantation: Operative techniques to optimize the recipient's outcome.成人对成人活体肝移植:优化受者结局的手术技术。
J Nat Sci Biol Med. 2017 Jan-Jun;8(1):4-10. doi: 10.4103/0976-9668.198356.